Distribution Agreement in Saudi Arabia and Jordan
News Jul 10, 2015
RaySearch Laboratories AB (publ.) has entered into a long-term distribution agreement with Trading Medical Systems Jordan (TMSJ) in Amman, Jordan. According to the agreement, TMSJ assumes full responsibility for the marketing, sales and service of RaySearch’s treatment planning system, RayStation®, in the markets of Saudi Arabia and Jordan.
TMSJ is a leading distributor of medical equipment used in the treatment of cancer and represents a wide range of respected international suppliers. The company was founded in 1995 and is well established in the radiation therapy, radiology and dosimetry market in Jordan with a dedicated and highly experienced sales and support team.
“TMSJ is honored to be representing RaySearch, that has a distinguished reputation to deliver highly innovative treatment planning solutions, in Saudi Arabia and Jordan. We are looking forward to promoting RayStation® to our customers in the region”, says Faris Al-Said, CEO of Trading Medical Systems Jordan.
“RayStation® is established as a world leading treatment planning system for radiation therapy and so far it has been sold to 20 different countries. We are excited to work with such an experienced partner as TMSJ to introduce RayStation® in Saudi Arabia and Jordan in order to serve customers in those countries in the best possible way”, says Johan Löf, CEO of RaySearch.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Nanoparticles Derived from Tea Leaves Destroy Lung Cancer CellsNews
Nanoparticles derived from tea leaves inhibit the growth of lung cancer cells, destroying up to 80% of them, new research by a joint Swansea University and Indian team has shown.